Michael ZürcherMar 191 min readINSIGHTSSuccess factors for foreign players entering the Swiss pharmaceuticals market
Michael ZürcherMay 15, 20242 min readINSIGHTSSwissmedic's 2023 report on human medicines: A leap forward in healthcare innovation
Michael ZürcherApr 10, 20242 min readINSIGHTSSwiss Pharmaceutical Market 2023: Further Growth Achieved
Michael ZürcherNov 22, 20231 min readINSIGHTSNew Opportunity in Swiss Market Access: Accelerated Access to Vital Medicines
Michael ZürcherSep 4, 20232 min readINSIGHTSSwitzerland’s Commitment to Healthcare as a Leader in Health Spending and Patent Application
Michael ZürcherApr 20, 20233 min readINSIGHTSArticle 71 KVV: The case-by-case approach to reimburse pharmaceuticals – a Swiss specialty
Michael ZürcherFeb 15, 20233 min readINSIGHTSMarket Access in Switzerland – or how to include medical breakthroughs on the specialties list
Michael ZürcherSep 14, 20224 min readINSIGHTSSwizzard Insight No. 5: How to bring medical breakthroughs to Switzerland faster
Michael ZürcherFeb 16, 20222 min readINSIGHTSSwizzard Insight No. 4: Project Orbis – how to accelerate your oncology breakthroughs in Switzerland
Michael ZürcherDec 1, 20211 min readINSIGHTSSwizzard Insight No. 3: How to win Switzerland with your medical breakthroughs
Michael ZürcherNov 24, 20212 min readINSIGHTSSwizzard Insight No. 2: The Swiss Federal Office of Public Health (FOPH)
